Prodia Diagnostic Line is trading at IDR 284, up +5.19%, with no clear company-specific announcement explaining the August 13, 2026 rebound.
- Recent coverage highlighted an IDR 8.84 billion first-half net loss and a 51.9% year-on-year revenue decline, which do not directly explain the gain.
- The stock remains volatile following an unusual-market-activity review by the Indonesia Stock Exchange.